Remedy publishes the financial statements release and the half-year review according to the disclosed annual schedule.
Event Date
Silent period and closed window 14.1.–14.2.2020
Full-year 2019 financial statements 14.2.2020
Annual Review 2019 Week 13 (23.–29.3.2020)
Annual General Meeting 6.4.2020
Silent period and closed window 14.7.–14.8.2020
Half-year 2020 financial review 14.8.2020

Regularly published financial reports are always preceded by a silent period of 30 days, during which Remedy does not issue statements on the financial position, business operations, markets or prospects.

During the silent period, the senior management of the company does not meet with investors, analysts or other capital market representatives, nor do they give interviews on the financial position of the company.